These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10412878)

  • 41. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
    Mroczek WJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between polymorphism of the angiotensin-converting enzyme gene and the response to angiotensin-converting enzyme inhibition in hypertensive patients.
    Yu H; Zhang Y; Liu G
    Hypertens Res; 2003 Nov; 26(11):881-6. PubMed ID: 14714579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens.
    Reneland R; Lithell H
    Scand J Clin Lab Invest; 1994 Apr; 54(2):105-11. PubMed ID: 8197396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial.
    Cheung BM; Lau CP
    Br J Clin Pharmacol; 1999 Feb; 47(2):179-87. PubMed ID: 10190653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype.
    Ohmichi N; Iwai N; Uchida Y; Shichiri G; Nakamura Y; Kinoshita M
    Am J Hypertens; 1997 Aug; 10(8):951-5. PubMed ID: 9270093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effects of treatment with atenolol and benazapril on 24-hour pressure variability].
    Prattichizzo FA; Galetta F
    Minerva Cardioangiol; 1993 Dec; 41(12):587-90. PubMed ID: 8139779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of the antihypertensive activity of fosinopril and irbesartan].
    Angulo E; Robles NR; Grois J; Barquero A; Pérez Miranda M
    An Med Interna; 2002 Nov; 19(11):571-5. PubMed ID: 12522893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C-reactive protein elevation predicts pulse pressure reduction in hypertensive subjects.
    Amar J; Ruidavets JB; Peyrieux JC; Mallion JM; Ferrières J; Safar ME; Chamontin B
    Hypertension; 2005 Jul; 46(1):151-5. PubMed ID: 15956115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antihypertensive treatment and CHD in the elderly.
    Fink KS; Ellsworth A
    Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract]   [Full Text] [Related]  

  • 55. Circulating angiotensin converting enzyme levels are increased in concentric, but not eccentric, left ventricular hypertrophy in elderly men.
    Reneland R; Andrén B; Lind L; Andersson PE; Hänni A; Lithell H
    J Hypertens; 1997 Aug; 15(8):885-90. PubMed ID: 9280212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.
    Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ
    Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.
    Pannier BM; Guerin AP; Marchais SJ; London GM
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1074-7. PubMed ID: 11903319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors.
    Takai S; Jin D; Sakaguchi M; Miyazaki M
    Hypertens Res; 2004 Mar; 27(3):213-9. PubMed ID: 15080380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
    Bhatnagar V; O'Connor DT; Schork NJ; Salem RM; Nievergelt CM; Rana BK; Smith DW; Bakris GL; Middleton JP; Norris KC; Wright JT; Cheek D; Hiremath L; Contreras G; Appel LJ; Lipkowitz MS
    J Hypertens; 2007 Oct; 25(10):2082-92. PubMed ID: 17885551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of a history of arterial hypertension and pretreatment blood pressure on the effect of angiotensin converting enzyme inhibition after acute myocardial infarction. Trandolapril Cardiac Evaluation Study.
    Gustafsson F; Køber L; Torp-Pedersen C; Per Hildebrandt
    J Hypertens Suppl; 1998 Jan; 16(1):S65-70. PubMed ID: 9534100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.